Literature DB >> 21957234

Synaptic and extrasynaptic NMDA receptors differentially modulate neuronal cyclooxygenase-2 function, lipid peroxidation, and neuroprotection.

David T Stark1, Nicolas G Bazan.   

Abstract

Stimulation of synaptic NMDA receptors (NMDARs) induces neuroprotection, while extrasynaptic NMDARs promote excitotoxic cell death. Neuronal expression of cyclooxygenase-2 (COX-2) is enhanced by synaptic NMDARs, and although this enzyme mediates neuronal functions, COX-2 is also regarded as a key modulator of neuroinflammation and is thought to exacerbate excitotoxicity via overproduction of prostaglandins. This raises an apparent paradox: synaptic NMDARs are pro-survival yet are essential for robust neuronal COX-2 expression. We hypothesized that stimulation of extrasynaptic NMDARs converts COX-2 signaling from a physiological to a potentially pathological process. We combined HPLC-electrospray ionization-tandem MS-based mediator lipidomics and unbiased image analysis in mouse dissociated and organotypic cortical cultures to uncover that synaptic and extrasynaptic NMDARs differentially modulate neuronal COX-2 expression and activity. We show that synaptic NMDARs enhance neuronal COX-2 expression, while sustained synaptic stimulation limits COX-2 activity by suppressing cellular levels of the primary COX-2 substrate, arachidonic acid (AA). In contrast, extrasynaptic NMDARs suppress COX-2 expression while activating phospholipase A₂, which enhances AA levels by hydrolysis of membrane phospholipids. Thus, sequential activation of synaptic then extrasynaptic NMDARs maximizes COX-2-dependent prostaglandin synthesis. We also show that excitotoxic events only drive induction of COX-2 expression through abnormal synaptic network excitability. Finally, we show that nonenzymatic lipid peroxidation of arachidonic and other polyunsaturated fatty acids is a function of network activity history. A new paradigm emerges from our results suggesting that pathological COX-2 signaling associated with models of stroke, epilepsy, and neurodegeneration requires specific spatiotemporal NMDAR stimulation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21957234      PMCID: PMC3197234          DOI: 10.1523/JNEUROSCI.3544-11.2011

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  67 in total

1.  Glutamate release in severe brain ischaemia is mainly by reversed uptake.

Authors:  D J Rossi; T Oshima; D Attwell
Journal:  Nature       Date:  2000-01-20       Impact factor: 49.962

2.  Suppressed accumulation of cerebral amyloid {beta} peptides in aged transgenic Alzheimer's disease mice by transplantation with wild-type or prostaglandin E2 receptor subtype 2-null bone marrow.

Authors:  C Dirk Keene; Rubens C Chang; Americo H Lopez-Yglesias; Bryan R Shalloway; Izabella Sokal; Xianwu Li; Patrick J Reed; Lisa M Keene; Kathleen S Montine; Richard M Breyer; Jason K Rockhill; Thomas J Montine
Journal:  Am J Pathol       Date:  2010-06-03       Impact factor: 4.307

3.  Memantine preferentially blocks extrasynaptic over synaptic NMDA receptor currents in hippocampal autapses.

Authors:  Peng Xia; Huei-sheng Vincent Chen; Dongxian Zhang; Stuart A Lipton
Journal:  J Neurosci       Date:  2010-08-18       Impact factor: 6.167

4.  Cyclooxygenase-2 contributes to functional hyperemia in whisker-barrel cortex.

Authors:  K Niwa; E Araki; S G Morham; M E Ross; C Iadecola
Journal:  J Neurosci       Date:  2000-01-15       Impact factor: 6.167

5.  Cyclooxygenase-2 contributes to N-methyl-D-aspartate-mediated neuronal cell death in primary cortical cell culture.

Authors:  S J Hewett; T F Uliasz; A S Vidwans; J A Hewett
Journal:  J Pharmacol Exp Ther       Date:  2000-05       Impact factor: 4.030

6.  Cyclooxygenase-2 generates anti-inflammatory mediators from omega-3 fatty acids.

Authors:  Alison L Groeger; Chiara Cipollina; Marsha P Cole; Steven R Woodcock; Gustavo Bonacci; Tanja K Rudolph; Volker Rudolph; Bruce A Freeman; Francisco J Schopfer
Journal:  Nat Chem Biol       Date:  2010-05-02       Impact factor: 15.040

7.  Prostaglandin E2-induced synaptic plasticity in neocortical networks of organotypic slice cultures.

Authors:  Henner Koch; Sung-Eun Huh; Frank P Elsen; Michael S Carroll; Rebecca D Hodge; Francesco Bedogni; Michael S Turner; Robert F Hevner; Jan-Marino Ramirez
Journal:  J Neurosci       Date:  2010-09-01       Impact factor: 6.167

Review 8.  Visualization of glutamate as a volume transmitter.

Authors:  Yohei Okubo; Masamitsu Iino
Journal:  J Physiol       Date:  2010-11-29       Impact factor: 5.182

Review 9.  Phospholipase A2 and arachidonic acid in Alzheimer's disease.

Authors:  Rene O Sanchez-Mejia; Lennart Mucke
Journal:  Biochim Biophys Acta       Date:  2010-05-27

Review 10.  Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders.

Authors:  Giles E Hardingham; Hilmar Bading
Journal:  Nat Rev Neurosci       Date:  2010-09-15       Impact factor: 34.870

View more
  26 in total

1.  Are cyclooxygenase-2 and nitric oxide involved in the dyskinesia of Parkinson's disease induced by L-DOPA?

Authors:  Mariza Bortolanza; Fernando E Padovan-Neto; Roberta Cavalcanti-Kiwiatkoski; Maurício Dos Santos-Pereira; Miso Mitkovski; Rita Raisman-Vozari; Elaine Del-Bel
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-07-05       Impact factor: 6.237

2.  Synaptic activity bidirectionally regulates a novel sequence-specific S-Q phosphoproteome in neurons.

Authors:  Benjamin Siddoway; Hailong Hou; Hongtian Yang; Ronald Petralia; Houhui Xia
Journal:  J Neurochem       Date:  2013-11-13       Impact factor: 5.372

Review 3.  Is there a molecular logic that sustains neuronal functional integrity and survival? Lipid signaling is necessary for neuroprotective neuronal transcriptional programs.

Authors:  Nicolas G Bazan
Journal:  Mol Neurobiol       Date:  2014-09-19       Impact factor: 5.590

Review 4.  Tau acts as a mediator for Alzheimer's disease-related synaptic deficits.

Authors:  Dezhi Liao; Eric C Miller; Peter J Teravskis
Journal:  Eur J Neurosci       Date:  2014-04       Impact factor: 3.386

5.  Novel aspirin-triggered neuroprotectin D1 attenuates cerebral ischemic injury after experimental stroke.

Authors:  Nicolas G Bazan; Tiffany N Eady; Larissa Khoutorova; Kristal D Atkins; Song Hong; Yan Lu; Changde Zhang; Bokkyoo Jun; Andre Obenaus; Gabrielle Fredman; Min Zhu; Jeremy W Winkler; Nicos A Petasis; Charles N Serhan; Ludmila Belayev
Journal:  Exp Neurol       Date:  2012-04-19       Impact factor: 5.330

6.  Cyclooxygenase inhibition targets neurons to prevent early behavioural decline in Alzheimer's disease model mice.

Authors:  Nathaniel S Woodling; Damien Colas; Qian Wang; Paras Minhas; Maharshi Panchal; Xibin Liang; Siddhita D Mhatre; Holden Brown; Novie Ko; Irene Zagol-Ikapitte; Marieke van der Hart; Taline V Khroyan; Bayarsaikhan Chuluun; Prachi G Priyam; Ginger L Milne; Arash Rassoulpour; Olivier Boutaud; Amy B Manning-Boğ; H Craig Heller; Katrin I Andreasson
Journal:  Brain       Date:  2016-05-13       Impact factor: 13.501

7.  Interneurons contribute to the hemodynamic/metabolic response to epileptiform discharges.

Authors:  Sandrine Saillet; Pascale P Quilichini; Antoine Ghestem; Bernard Giusiano; Anton I Ivanov; Sebastian Hitziger; Ivo Vanzetta; Christophe Bernard; Christian-G Bénar
Journal:  J Neurophysiol       Date:  2015-12-23       Impact factor: 2.714

8.  Inhibition of GluN2A-containing N-methyl-D-aspartate receptors by 2-naphthoic acid.

Authors:  Han Yu; Gabriela K Popescu
Journal:  Mol Pharmacol       Date:  2013-07-19       Impact factor: 4.436

Review 9.  Lipoxygenase: an emerging target for stroke therapy.

Authors:  Klaus van Leyen
Journal:  CNS Neurol Disord Drug Targets       Date:  2013-03       Impact factor: 4.388

Review 10.  Docosanoids and elovanoids from omega-3 fatty acids are pro-homeostatic modulators of inflammatory responses, cell damage and neuroprotection.

Authors:  Nicolas G Bazan
Journal:  Mol Aspects Med       Date:  2018-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.